Next-Gen Implant Systems

About SpineSmith

SpineSmith operates at the intersection of medical device engineering and regenerative medicine, focusing on spinal pathologies. Its technology platform combines advanced manufacturing like 3D printing with biomaterials science to create implants designed to interface biologically with the human body. The company appears to be commercial-stage, offering products and is associated with Celling Biosciences, a pioneer in autologous cell therapy. It targets the large and growing market for spinal fusion and orthopedic biologics with a differentiated, biology-first approach.

Therapeutic Areas